To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution (Powder in Bottle).
Conditions
Interventions
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: BI 660848
- DRUG: Placebo
Sponsor
Boehringer Ingelheim